Literature DB >> 21095210

Antibody derivatization and conjugation strategies: application in preparation of stealth immunoliposome to target chemotherapeutics to tumor.

Arehalli S Manjappa1, Kiran R Chaudhari, Makam P Venkataraju, Prudhviraju Dantuluri, Biswarup Nanda, Chennakesavulu Sidda, Krutika K Sawant, Rayasa S Ramachandra Murthy.   

Abstract

A great deal of effort has been made over the years to develop liposomes that have targeting vectors (oligosaccharides, peptides, proteins and vitamins) attached to the bilayer surface. Most studies have focused on antibody conjugates since procedures for producing highly specific monoclonal antibodies are well established. Antibody conjugated liposomes have recently attracted a great deal of interest, principally because of their potential use as targeted drug delivery systems and in diagnostic applications. A number of methods have been reported for coupling antibodies to the surface of stealth liposomes. The objective of this review is to enumerate various strategies which are employed in the modification and conjugation of antibodies to the surface of stealth liposomes. This review also describes various derivatization techniques of lipids prior and after their use in the preparation of liposomes. The use of single chain variable fragments and affibodies as targeting ligands in the preparation of immunoliposomes is also discussed.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21095210     DOI: 10.1016/j.jconrel.2010.11.002

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  53 in total

1.  Fabrication and Characterization of Hybrid Stealth Liposomes.

Authors:  Kenneth P Mineart; Shrinivas Venkataraman; Yi Yan Yang; James L Hedrick; Vivek M Prabhu
Journal:  Macromolecules       Date:  2018-04-12       Impact factor: 5.985

2.  Etoposide-loaded immunoliposomes as active targeting agents for GD2-positive malignancies.

Authors:  Brandon S Brown; Tariq Patanam; Keyan Mobli; Christian Celia; Peter E Zage; Andrew J Bean; Ennio Tasciotti
Journal:  Cancer Biol Ther       Date:  2014-04-22       Impact factor: 4.742

Review 3.  Engineering liposomal nanoparticles for targeted gene therapy.

Authors:  C Zylberberg; K Gaskill; S Pasley; S Matosevic
Journal:  Gene Ther       Date:  2017-05-15       Impact factor: 5.250

4.  Interaction between C18 fatty acids and DOPE PEG2000 in Langmuir monolayers: effect of degree of unsaturation.

Authors:  Lai Ti Gew; Misni Misran
Journal:  J Biol Phys       Date:  2017-07-27       Impact factor: 1.365

5.  High-affinity peptide against MT1-MMP for in vivo tumor imaging.

Authors:  Lei Zhu; Huiling Wang; Lin Wang; Ye Wang; Kun Jiang; Cheng Li; Qingjie Ma; Shi Gao; Liping Wang; Wei Li; Mingjun Cai; Hongda Wang; Gang Niu; Seulki Lee; Wei Yang; Xuexun Fang; Xiaoyuan Chen
Journal:  J Control Release       Date:  2011-02-02       Impact factor: 9.776

6.  The enhanced delivery of salinomycin to CD133+ ovarian cancer stem cells through CD133 antibody conjugation with poly(lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles.

Authors:  Yi Mi; Yuqin Huang; Jie Deng
Journal:  Oncol Lett       Date:  2018-03-01       Impact factor: 2.967

Review 7.  Designer lipids for drug delivery: from heads to tails.

Authors:  Aditya G Kohli; Paul H Kierstead; Vincent J Venditto; Colin L Walsh; Francis C Szoka
Journal:  J Control Release       Date:  2014-05-06       Impact factor: 9.776

8.  Overcoming nonviral gene delivery barriers: perspective and future.

Authors:  Charles H Jones; Chih-Kuang Chen; Anitha Ravikrishnan; Snehal Rane; Blaine A Pfeifer
Journal:  Mol Pharm       Date:  2013-10-16       Impact factor: 4.939

9.  A Polymeric Nanogel-Based Treatment Regimen for Enhanced Efficacy and Sequential Administration of Synergistic Drug Combination in Pancreatic Cancer.

Authors:  Kruti S Soni; Divya Thomas; Thomas Caffrey; Kamiya Mehla; Fan Lei; Kelly A O'Connell; Satish Sagar; Subodh M Lele; Michael A Hollingsworth; Prakash Radhakrishnan; Tatiana K Bronich
Journal:  J Pharmacol Exp Ther       Date:  2019-01-25       Impact factor: 4.030

10.  Multifunctional Transmembrane Protein Ligands for Cell-Specific Targeting of Plasma Membrane-Derived Vesicles.

Authors:  Chi Zhao; David J Busch; Connor P Vershel; Jeanne C Stachowiak
Journal:  Small       Date:  2016-06-13       Impact factor: 13.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.